v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Income/(Loss)
Retained Earnings
Noncontrolling Interests
Beginning balance at Dec. 31, 2024 $ 2,286,213 $ 7,175 $ 183,250 $ (502,734) $ 2,583,923 $ 14,599
Beginning balance (in shares) at Dec. 31, 2024   98,260        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 54,489       54,429 60
Other comprehensive (loss)/income:            
Translation gain/(loss) 175,839     175,864   (25)
Defined benefit plan adjustment, net of tax 544     544    
Derivative financial instruments, net of tax 1,757     1,757    
Other comprehensive income/(loss) 178,140     178,165   (25)
Divestiture of non-controlling interest (637)         (637)
Dividends (51,558)       (51,558)  
Dividends paid to noncontrolling interests (243)         (243)
Issuance of stock awards 273   273      
Issuance of stock awards (in shares)   588        
Shares repurchased (10,573)   (10,573)      
Shares repurchased (in shares)   (220)        
Share-based compensation 5,828   5,828      
Ending balance at Mar. 30, 2025 2,461,932 $ 7,175 178,778 (324,569) 2,586,794 13,754
Ending balance (in shares) at Mar. 30, 2025   98,628        
Beginning balance at Dec. 31, 2024 2,286,213 $ 7,175 183,250 (502,734) 2,583,923 14,599
Beginning balance (in shares) at Dec. 31, 2024   98,260        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 547,688          
Other comprehensive (loss)/income:            
Translation gain/(loss) 515,291          
Defined benefit plan adjustment, net of tax 3,479          
Derivative financial instruments, net of tax 3,081          
Other comprehensive income/(loss) 521,851          
Ending balance at Jun. 29, 2025 3,250,833 $ 7,175 183,339 17,363 3,027,647 15,309
Ending balance (in shares) at Jun. 29, 2025   98,628        
Beginning balance at Dec. 31, 2024 2,286,213 $ 7,175 183,250 (502,734) 2,583,923 14,599
Beginning balance (in shares) at Dec. 31, 2024   98,260        
Ending balance at Dec. 31, 2025 $ 3,631,832 [1] $ 7,175 191,855 37,204 3,377,647 17,951
Ending balance (in shares) at Dec. 31, 2025 98,634 98,634        
Beginning balance at Mar. 30, 2025 $ 2,461,932 $ 7,175 178,778 (324,569) 2,586,794 13,754
Beginning balance (in shares) at Mar. 30, 2025   98,628        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 493,199       493,423 (224)
Other comprehensive (loss)/income:            
Translation gain/(loss) 339,452     337,673   1,779
Defined benefit plan adjustment, net of tax 2,935     2,935    
Derivative financial instruments, net of tax 1,324     1,324    
Other comprehensive income/(loss) 343,711     341,932   1,779
Dividends (52,570)       (52,570)  
Issuance of stock awards 298   298      
Issuance of stock awards (in shares)   0        
Shares repurchased (3)   (3)      
Shares repurchased (in shares)   0        
Share-based compensation 4,145   4,145      
Other 121   121      
Ending balance at Jun. 29, 2025 3,250,833 $ 7,175 183,339 17,363 3,027,647 15,309
Ending balance (in shares) at Jun. 29, 2025   98,628        
Beginning balance at Dec. 31, 2025 $ 3,631,832 [1] $ 7,175 191,855 37,204 3,377,647 17,951
Beginning balance (in shares) at Dec. 31, 2025 98,634 98,634        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 67,625       67,601 24
Other comprehensive (loss)/income:            
Translation gain/(loss) (61,644)     (61,362)   (282)
Defined benefit plan adjustment, net of tax 739     739    
Derivative financial instruments, net of tax 928     928    
Other comprehensive income/(loss) (59,977)     (59,695)   (282)
Dividends (52,735)       (52,735)  
Issuance of stock awards 332   332      
Issuance of stock awards (in shares)   367        
Shares repurchased (6,954)   (6,954)      
Shares repurchased (in shares)   (132)        
Share-based compensation 6,174   6,174      
Other 70   70      
Ending balance at Mar. 29, 2026 3,586,367 $ 7,175 191,477 (22,491) 3,392,513 17,693
Ending balance (in shares) at Mar. 29, 2026   98,869        
Beginning balance at Dec. 31, 2025 $ 3,631,832 [1] $ 7,175 191,855 37,204 3,377,647 17,951
Beginning balance (in shares) at Dec. 31, 2025 98,634 98,634        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 172,649          
Other comprehensive (loss)/income:            
Translation gain/(loss) (111,206)          
Defined benefit plan adjustment, net of tax 4,310          
Derivative financial instruments, net of tax 1,842          
Other comprehensive income/(loss) (105,054)          
Ending balance at Jun. 28, 2026 $ 3,598,523 $ 7,175 197,408 (67,207) 3,443,685 17,462
Ending balance (in shares) at Jun. 28, 2026 98,869 98,869        
Beginning balance at Mar. 29, 2026 $ 3,586,367 $ 7,175 191,477 (22,491) 3,392,513 17,693
Beginning balance (in shares) at Mar. 29, 2026   98,869        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 105,024       104,894 130
Other comprehensive (loss)/income:            
Translation gain/(loss) (49,562)     (49,201)   (361)
Defined benefit plan adjustment, net of tax 3,571     3,571    
Derivative financial instruments, net of tax 914     914    
Other comprehensive income/(loss) (45,077)     (44,716)   (361)
Dividends (53,722)       (53,722)  
Issuance of stock awards 336   336      
Issuance of stock awards (in shares)   0        
Shares repurchased (57)   (57)      
Shares repurchased (in shares)   0        
Share-based compensation 5,731   5,731      
Other (79)   (79)      
Ending balance at Jun. 28, 2026 $ 3,598,523 $ 7,175 $ 197,408 $ (67,207) $ 3,443,685 $ 17,462
Ending balance (in shares) at Jun. 28, 2026 98,869 98,869        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).